Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment
Hannes A. Baukmann, Justin L. Cope, Charles N. J. Ravarani, Colin Bannard, Margaretha R. J. Lamparter, Alexander R. E. C. Schwinges, Joern E. Klinger, Marco Florian Schmidt
The paper identifies high neutrophil count as a causal trait in severe COVID-19 and suggests CDK6 inhibitors as potential treatment.
medRxiv · May 18, 2021 · PreprintGenetic & Genomic Medicine